Retagliptin
- Generic Name
- Retagliptin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18F6N4O3
- CAS Number
- 1174122-54-3
- Unique Ingredient Identifier
- 328C4R3P9L
- Background
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
- Indication
用于改善成人2型糖尿病患者的血糖控制。
①单药：本品单药可配合饮食控制和运动，改善成人2型糖尿病患者的血糖控制。
②与盐酸二甲双胍联合使用：在单独使用盐酸二甲双胍血糖控制不佳时，本品可与盐酸二甲双胍联合使用，配合饮食和运动改善成人2型糖尿病患者的血糖控制。
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath